Lemtrada® (alemtuzumab)
for Multiple Sclerosis

Lemtrada (alemtuzumab) is used to treat relapsing forms of multiple sclerosis in people 17 and older, including active secondary progressive disease, after at least two prior treatments have failed. While it does not cure MS, it can reduce the frequency of relapses and may delay or prevent disability. Lemtrada works by preventing immune system cells (lymphocytes) from attacking nerves in the brain and spinal cord, helping to slow disease progression.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Multiple Sclerosis - MS